Jun 06, 2018
Western European Cardiac Troponin Diagnostics Market to 2021
Mar 28, 2018
Introducing Heel Defender(TM) Orthotic Shoe Inserts
Mar 21, 2018
Study shows cardiac troponin measurement using ultra-sensitive Singulex cTnI test can identify the presence and severity of coronary artery disease in stable, symptomatic outpatients
Mar 13, 2018
Study adds to understanding about utility of ultra-sensitive cardiac troponin measurement in diagnosing and predicting cardiovascular syndromes
Mar 05, 2018
Orthopedic Orthotics Market Expected to Reach $4,685 Million, Globally, by 2023 - Allied Market Research
Feb 28, 2018
Study shows high-sensitivity cardiac troponin I concentration, measured with the Singulex cTnI assay, is an independent predictor of obstructive coronary artery disease in patients with suspected stable angina
Dec 06, 2017
MYOS RENS Technology Enters Into Research Agreement With University Of California, Berkeley To Study Effects Of Fortetropin® On Skeletal Muscle Protein Synthetic Rate In Older Men And Women
Dec 01, 2017
OTC Braces and Supports Market Worth 1.42 Billion USD by 2022
Nov 01, 2017
Singulex announces 510(k) submission for the first ultra-sensitive cardiac troponin I (cTnI) test using Single Molecule Counting technology
Sep 15, 2017
Orthopedic Braces and Supports Market Worth 4.93 Billion USD by 2022
Sep 08, 2017
Singulex Receives New, Broad Patent For Digital Detection Of Cardiac Troponin-I Or Cardiac Troponin-T For Coronary Artery Disease Rule-Out
Sep 06, 2017
Bioness to Showcase Lower Extremity Product Portfolio at the American Orthotic & Prosthetic Association World Congress
Aug 15, 2017
Europe Market Report for Rotator Cuff Repair 2017 - MedCore
Aug 14, 2017
World Cardiac Marker Analyzer Product Analysis, Cardiac Marker Companies Business & Marketing Strategy Research Report 2017
Aug 14, 2017
Study Hints at Experimental Therapy for Heart Fibrosis
Aug 01, 2017
Evaluations of the Analytical Performance of the Singulex Cardiac Troponin I Assay Used on its Single Molecule Counting Technology Platform Demonstrates Ability to Improve Cardiovascular Disease Rule-Out
Jul 31, 2017
Myomo, Inc. Obtains CE Mark Approval for MyoPro®
Jun 27, 2017
Myomo, Inc. Announces Publication of Significant Clinical Research
Jun 13, 2017
Myomo, Inc. Launches MyoPro® 2
Jun 01, 2017
First ultra-sensitive cardiac troponin (cTnI) test using Single Molecule Counting technology receives CE Mark